Short-acting drugs include exenatide twice daily, lixisenatide once daily and oral semaglutide once daily, while long-acting drugs include liraglutide, semaglutide, exenatide, albiglutide and dulaglutide all being administered once weekly
The injection lasts about a week
The module will emphasize the pharmacology and key clinical effects of these drugs and describe how each medication class fits into treatment paradigms currently outlined in clinical recommendations established by the American Diabetes Association (ADA) and the American Association of Clinical Endocrinologists (AACE)/American College of Endocrinology (ACE)
1.1 Review methodology and scope This review constitutes a narrative and conceptual synthesis rather than a systematic meta-analysis
100% Ingredients from Europe & USA with NO: Artificial Preservatives/Flavorings, Sweeteners, Soy, Gluten, or Alcohol - Made in USA